Refractory congestion is common in acute and chronic heart failure, and it significantly
impacts functional class, renal function, hospital admissions, and survival. In this paper, the …

Introduction Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl− cotransporter type 2 in
the thick ascending loop of Henle, leading to increased excretion of urinary sodium and …

Objective: To frame revised guidelines on diagnosis, evaluation, management, and
supportive care of patients with the illness. Process: The guidelines combine evidence …

El síndrome cardiorrenal es una entidad compleja en la que la disfunción primaria cardíaca
produce daño renal (tipos 1 y 2) y viceversa (tipos 3 y 4) y los episodios pueden ser agudos …

Fluid overload secondary to loss of functional nephron mass can elevate blood pressure,
which is characteristic of hypertension shown in chronic kidney disease (CKD). Therefore, it …

The pharmacologic management of HFpEF is an evolving field. Symptomatic management
with diuretics and optimization of comorbidities remain important components of therapy …

Heart failure remains a huge societal concern despite medical advancement, with an annual
direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to …

Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF)
trial Page 1 European Heart Journal: Acute Cardiovascular Care (2022) 11, 931–932 https://doi.org/10.1093/ehjacc/zuac144 …

To the Editor, Heart failure (HF) is a leading cause of morbidity and mortality globally. 1 Loop
diuretics, such as torsemide and furosemide, are routinely used for managing fluid overload …

The cardiorenal syndrome is a complex entity in which a primary heart dysfunction causes
kidney injury (types 1 and 2) and vice versa (Types 3 and 4), being either acute or chronic …